Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vascular Solutions Inc Reaffirms FY 2013 Guidance; Issues Q2 2013 In Line With Analysts' Estimates


Tuesday, 23 Apr 2013 04:05pm EDT 

Vascular Solutions Inc announced that for fiscal 2013, it maintaining guidance for net revenue of between $106 million and $110 million and net earnings, adjusted to exclude the effects of the Guardian product recall, of between $0.66 and $0.70 per fully diluted share, which at the mid-point represents growth of 13% from $0.60 in 2012. On a GAAP basis, this adjusted earnings guidance corresponds to net earnings of between $0.62 and $0.66 per fully diluted share. For the second quarter of 2013, it expects net revenue of between $26.5 million and $27.5 million and net earnings to be between $0.16 and $0.17 per fully diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $109 million and EPS of $0.67 for fiscal 2013; revenue of $27.4 million and EPS of $0.17 for the second quarter of 2013. 

Company Quote

27.5
-0.07 -0.25%
12:29pm EST